Onco-Innovations signs LOI with Ifowonco for LAG-3 inhibitor licence
Onco-Innovations (as listed in the alert) enters into a LOI with Ifowonco for an exclusive option and worldwide licence tied to a LAG-3 small-molecule inhibitor program.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.